Intravitreal bevacizumab as an adjunctive therapy before diabetic vitrectomy

PURPOSE: To evaluate the effect of intravitreal injection of Avastin, bevacizumab (IVA) on diabetic vitrectomy and on the postoperative course. METHODS: Thirty patients undergoing diabetic vitrectomy were distributed to standard vitrectomy (group 1) or vitrectomy with preoperative IVA (group 2). Bev...

Descripción completa

Detalles Bibliográficos
Autor principal: El-Batarny, Ashraf M
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2008
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2699790/
https://www.ncbi.nlm.nih.gov/pubmed/19668420

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2699790/
https://www.ncbi.nlm.nih.gov/pubmed/19668420

Ejemplares similares